Pietro L Vernazza
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
Lichtensteiger C, Koblischke M, Berner F, Jochum A, Sinnberg T, Balciunaite B, Purde M, Walter V, Abdou M, Hofmeister K, Kohler P, Vernazza P, Albrich W, Kahlert C, Zoufaly A, Traugott M, Kern L, Pietsch U, Kleger G, Filipovic M, Kneilling M, Cozzio A, Pop O, Bomze D, Bergthaler A, Hasan A, Aberle J, Flatz L. Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients. J Autoimmun 2023; 140:103118.
Oct 10, 2023Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patients.
Oct 10, 2023J Autoimmun 2023; 140:103118
Lichtensteiger Christa, Koblischke Maximilian, Berner Fiamma, Jochum Ann-Kristin, Sinnberg Tobias, Balciunaite Beatrice, Purde Mette-Triin, Walter Vincent, Abdou Marie-Therese, Hofmeister Kathrin, Kohler Philipp, Vernazza Pietro L, Albrich Werner, Kahlert Christian, Zoufaly Alexander, Traugott Marianna T, Kern Lukas, Pietsch Urs, Kleger Gian-Reto, Filipovic Miodrag, Kneilling Manfred, Cozzio Antonio, Pop Oltin, Bomze David, Bergthaler Andreas, Hasan Ali, Aberle Judith, Flatz Lukas
Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'.
Bertisch B, Schaetti C, Schmid P, Peter L, Vernazza P, Isler M, Oppliger R, Schmidt A. Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'. J Viral Hepat 2023; 31:53-56.
Oct 7, 2023Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'.
Oct 7, 2023J Viral Hepat 2023; 31:53-56
Bertisch Barbara, Schaetti Christian, Schmid Patrick, Peter Laura, Vernazza Pietro L, Isler Marc, Oppliger Robert, Schmidt Axel Jeremias
Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
Kahlert C, Strahm C, Güsewell S, Cusini A, Brucher A, Goppel S, Möller E, Möller J, Ortner M, Ruetti M, Stocker R, Vuichard-Gysin D, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kuster S, Kohler P, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group. Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study. Clin Infect Dis 2023; 77:194-202.
Jul 26, 2023Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study.
Jul 26, 2023Clin Infect Dis 2023; 77:194-202
Kahlert Christian, Strahm Carol, Güsewell Sabine, Cusini Alexia, Brucher Angela, Goppel Stephan, Möller Elisabeth, Möller J. Carsten, Ortner Manuela, Ruetti Markus, Stocker Reto, Vuichard-Gysin Danielle, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kuster Stefan, Kohler Philipp, SURPRISE (SURveillance of infectious diseases among health PRofessionals In SwitzErland) Study Group
Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
Kohler P, Babouee Flury B, Güsewell S, Egger T, Leal-Neto O, Brucher A, Lemmenmeier E, Meier Kleeb D, Möller J, Ortner M, Rieder P, Ruetti M, Schmid H, Stocker R, Vuichard-Gysin D, Speer O, Wiggli B, Besold U, McGeer A, Risch L, Friedl A, Schlegel M, Vernazza P, Kahlert C, Kuster S, SURPRISE Study Group. Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study). Influenza Other Respir Viruses 2023; 17:e13167.
Jun 19, 2023Clinical symptoms of SARS-CoV-2 breakthrough infection during the Omicron period in relation to baseline immune status and booster vaccination-A prospective multicentre cohort of health professionals (SURPRISE study).
Jun 19, 2023Influenza Other Respir Viruses 2023; 17:e13167
Kohler Philipp, Babouee Flury Baharak, Güsewell Sabine, Egger Thomas, Leal-Neto Onicio B, Brucher Angela, Lemmenmeier Eva, Meier Kleeb Dorette, Möller J. Carsten, Ortner Manuela, Rieder Philippe, Ruetti Markus, Schmid Hans Ruedi, Stocker Reto, Vuichard-Gysin Danielle, Speer Oliver, Wiggli Benedikt, Besold Ulrike, McGeer Allison J, Risch Lorenz, Friedl Andree, Schlegel Matthias, Vernazza Pietro L, Kahlert Christian, Kuster Stefan, SURPRISE Study Group
Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets.
Bertisch B, Schaetti C, Schmid P, Peter L, Vernazza P, Isler M, Oppliger R, Schmidt A. Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets. J Viral Hepat 2023; 30:667-684.
Jun 6, 2023Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets.
Jun 6, 2023J Viral Hepat 2023; 30:667-684
Bertisch Barbara, Schaetti Christian, Schmid Patrick, Peter Laura, Vernazza Pietro L, Isler Marc, Oppliger Robert, Schmidt Axel Jeremias
Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
Sumer J, Keckeis K, Scanferla G, Frischknecht M, Notter J, Steffen A, Kohler P, Schmid P, Roth B, Wissel K, Vernazza P, Klein P, Schoop R, Albrich W. Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial. Front Med (Lausanne) 2023; 10:948787.
Apr 17, 2023Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.
Apr 17, 2023Front Med (Lausanne) 2023; 10:948787
Sumer Johannes, Keckeis Karin, Scanferla Giulia, Frischknecht Manuel, Notter Julia, Steffen Ana, Kohler Philipp, Schmid Patrick, Roth Bianca, Wissel Kerstin, Vernazza Pietro L, Klein Peter, Schoop Roland, Albrich Werner
Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.
Hovaguimian F, Martin-Diener E, Reinacher M, Rasi M, Schmidt A, Bernasconi E, Boffi El Amari E, Braun D, Calmy A, Darling K, Christinet V, Depmeier C, Hauser-Kronberger C, Läuchli S, Notter J, Stoeckle M, Surial B, Vernazza P, Bruggmann P, Tarr P, Haerry D, Bize R, Low N, Lehner A, Böni J, Kouyos R, Fehr J, Hampel B. Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection. HIV Med 2021; 23:146-158.
Oct 3, 2021Participation, retention and uptake in a multicentre pre-exposure prophylaxis cohort using online, smartphone-compatible data collection.
Oct 3, 2021HIV Med 2021; 23:146-158
Hovaguimian Frédérique, Martin-Diener Eva, Reinacher Matthias, Rasi Manuela, Schmidt Axel Jeremias, Bernasconi Enos, Boffi El Amari Emnanuelle, Braun Dominique Laurent, Calmy Alexandra, Darling Katharine Elizabeth Anna, Christinet Vanessa, Depmeier Carsten, Hauser-Kronberger C, Läuchli Severin, Notter Julia, Stoeckle Marcel, Surial Bernard, Vernazza Pietro L, Bruggmann Phillipe, Tarr Philip X00a0 E, Haerry David, Bize Raphaël, Low Nicolas, Lehner Andreas, Böni Jürg, Kouyos Roger D, Fehr Jan S, Hampel Benjamin